How can Corus™ CAD inform on a possible blockage in your coronary arteries?
In 2003, the completion of the Human Genome Project created a new medical field called genomic medicine, making it possible for physicians to further individualize care based on each patient’s unique genomic makeup. The Corus CAD gene expression test was developed through the ground-breaking work of CardioDx in this new medical field.
Corus CAD:
- Is a blood-based test that measures the expression levels, or activity, of 23 genes that have demonstrated to indicate obstructive* coronary artery disease (CAD)
- Gives your physician a score that indicates the likelihood that you have obstructive CAD
- Provides your physician with unique and objective information about what may be causing your chest pain symptoms
- Is simple, safe and convenient, requiring only a routine blood draw
Your physician will use the results of Corus CAD along with his or her standard clinical evaluation to identify your likelihood of having obstructive CAD.
* Obstructive CAD is defined as at least one atherosclerotic plaque causing ≥50% luminal diameter stenosis in a major coronary artery (≥1.5 mm lumen diameter) as determined by invasive quantitative coronary angiography (QCA).